Ontrak, Inc. (OTRKP)
USD 0.25
(-9.42%)
USD 0.25
(-9.42%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.68 Million USD | -85.01% |
| 2022 | 11.26 Million USD | -69.93% |
| 2021 | 37.45 Million USD | -21.93% |
| 2020 | 47.97 Million USD | 40.34% |
| 2019 | 34.18 Million USD | 357.51% |
| 2018 | 7.47 Million USD | 373500.0% |
| 2017 | 2000.00 USD | -99.98% |
| 2016 | 9.82 Million USD | 163.6% |
| 2015 | 3.72 Million USD | 16108.7% |
| 2014 | 23 Thousand USD | -11.54% |
| 2013 | 26 Thousand USD | 44.44% |
| 2012 | 18 Thousand USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 5.82 Million USD | -39.9% |
| 2009 | 9.69 Million USD | -21.34% |
| 2008 | 12.32 Million USD | 72.79% |
| 2007 | 7.13 Million USD | 3796.17% |
| 2006 | 183 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 175.99 Thousand USD | 6970.75% |
| 2001 | 2489.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6.86 Million USD | 275.92% |
| 2024 Q1 | 1.82 Million USD | 8.17% |
| 2023 Q3 | 14.29 Million USD | 17.56% |
| 2023 Q2 | 12.15 Million USD | 20.71% |
| 2023 Q1 | 10.07 Million USD | -10.57% |
| 2023 FY | 1.68 Million USD | -85.01% |
| 2023 Q4 | 1.68 Million USD | -88.18% |
| 2022 Q4 | 11.26 Million USD | 6.34% |
| 2022 Q3 | 10.59 Million USD | 37.24% |
| 2022 Q2 | 7.71 Million USD | -56.58% |
| 2022 Q1 | 17.77 Million USD | -52.54% |
| 2022 FY | 11.26 Million USD | -69.93% |
| 2021 Q3 | 48.17 Million USD | 0.07% |
| 2021 Q2 | 48.14 Million USD | 0.05% |
| 2021 Q1 | 48.11 Million USD | 0.3% |
| 2021 FY | 37.45 Million USD | -21.93% |
| 2021 Q4 | 37.45 Million USD | -22.25% |
| 2020 Q4 | 47.97 Million USD | 0.12% |
| 2020 FY | 47.97 Million USD | 40.34% |
| 2020 Q1 | 35.71 Million USD | 4.47% |
| 2020 Q2 | 37.23 Million USD | 4.26% |
| 2020 Q3 | 47.91 Million USD | 28.69% |
| 2019 Q1 | 10.02 Million USD | 34.21% |
| 2019 Q4 | 34.18 Million USD | 5.68% |
| 2019 Q3 | 32.34 Million USD | 81.32% |
| 2019 FY | 34.18 Million USD | 357.51% |
| 2019 Q2 | 17.84 Million USD | 77.9% |
| 2018 FY | 7.47 Million USD | 373500.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | 4.86 Million USD | 0.0% |
| 2018 Q3 | 7.41 Million USD | 52.42% |
| 2018 Q4 | 7.47 Million USD | 0.77% |
| 2017 Q2 | 14 Thousand USD | -99.86% |
| 2017 FY | 2000.00 USD | -99.98% |
| 2017 Q1 | 10.06 Million USD | 2.45% |
| 2017 Q4 | 2000.00 USD | -66.67% |
| 2017 Q3 | 6000.00 USD | -57.14% |
| 2016 Q3 | 8.68 Million USD | 41.0% |
| 2016 Q2 | 6.16 Million USD | 30.7% |
| 2016 FY | 9.82 Million USD | 163.6% |
| 2016 Q1 | 4.71 Million USD | 26.45% |
| 2016 Q4 | 9.82 Million USD | 13.12% |
| 2015 FY | 3.72 Million USD | 16108.7% |
| 2015 Q4 | 3.72 Million USD | 84.1% |
| 2015 Q3 | 2.02 Million USD | -13.79% |
| 2015 Q2 | 2.34 Million USD | 977.52% |
| 2015 Q1 | 218 Thousand USD | 847.83% |
| 2014 Q3 | 23 Thousand USD | 15.0% |
| 2014 Q4 | 23 Thousand USD | 0.0% |
| 2014 FY | 23 Thousand USD | -11.54% |
| 2014 Q1 | 24 Thousand USD | -7.69% |
| 2014 Q2 | 20 Thousand USD | -16.67% |
| 2013 Q3 | 18 Thousand USD | -10.0% |
| 2013 Q2 | 20 Thousand USD | 33.33% |
| 2013 Q1 | 15 Thousand USD | -16.67% |
| 2013 FY | 26 Thousand USD | 44.44% |
| 2013 Q4 | 26 Thousand USD | 44.44% |
| 2012 Q1 | 604 Thousand USD | 0.0% |
| 2012 FY | 18 Thousand USD | 0.0% |
| 2012 Q2 | - USD | -100.0% |
| 2012 Q3 | 21 Thousand USD | 0.0% |
| 2012 Q4 | 18 Thousand USD | -14.29% |
| 2011 Q1 | 2000.00 USD | -99.97% |
| 2011 FY | - USD | -100.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q3 | 213 Thousand USD | 0.0% |
| 2011 Q4 | - USD | -100.0% |
| 2010 Q3 | 7000.00 USD | -99.79% |
| 2010 Q2 | 3.33 Million USD | -64.85% |
| 2010 Q4 | 5.82 Million USD | 83100.0% |
| 2010 FY | 5.82 Million USD | -39.9% |
| 2010 Q1 | 9.48 Million USD | -2.14% |
| 2009 Q2 | 10.93 Million USD | 3.9% |
| 2009 Q1 | 10.52 Million USD | -14.56% |
| 2009 Q4 | 9.69 Million USD | 0.6% |
| 2009 Q3 | 9.63 Million USD | -11.92% |
| 2009 FY | 9.69 Million USD | -21.34% |
| 2008 Q3 | 11.58 Million USD | 58.84% |
| 2008 Q4 | 12.32 Million USD | 6.35% |
| 2008 Q1 | 7.2 Million USD | 1.02% |
| 2008 FY | 12.32 Million USD | 72.79% |
| 2008 Q2 | 7.29 Million USD | 1.25% |
| 2007 Q1 | 11.19 Million USD | 6015.3% |
| 2007 Q3 | 11.65 Million USD | 2.07% |
| 2007 Q2 | 11.42 Million USD | 2.06% |
| 2007 FY | 7.13 Million USD | 3796.17% |
| 2007 Q4 | 7.13 Million USD | -38.84% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | 183 Thousand USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | 183 Thousand USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q1 | 226.99 Thousand USD | 28.98% |
| 2002 Q4 | 175.99 Thousand USD | 0.0% |
| 2002 FY | 175.99 Thousand USD | 6970.75% |
| 2002 Q1 | 20.59 Thousand USD | 0.0% |
| 2001 FY | 2489.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 897.3 Million USD | 99.812% |
| GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.983% |
| Sharecare, Inc. | 2.34 Million USD | 27.974% |
| Progyny, Inc. | 19.39 Million USD | 91.289% |
| Aclarion, Inc. | 1.12 Million USD | -50.037% |
| CareMax, Inc. | 491.93 Million USD | 99.657% |
| Simulations Plus, Inc. | 475 Thousand USD | -255.579% |
| CareCloud, Inc. | 14.73 Million USD | 88.536% |
| Forian Inc. | 23 Million USD | 92.657% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 39.69 Million USD | 95.745% |
| Omnicell, Inc. | 614.09 Million USD | 99.725% |
| Definitive Healthcare Corp. | 267.92 Million USD | 99.37% |
| Zhongchao Inc. | 808.15 Thousand USD | -108.994% |
| Accolade, Inc. | 241.64 Million USD | 99.301% |
| Streamline Health Solutions, Inc. | 10.56 Million USD | 84.015% |
| SOPHiA GENETICS SA | 18.6 Million USD | 90.92% |
| R1 RCM Inc. | 1.74 Billion USD | 99.903% |
| Spok Holdings, Inc. | 11.08 Million USD | 84.765% |
| Privia Health Group, Inc. | 8.28 Million USD | 79.624% |
| EUDA Health Holdings Limited | 3.37 Million USD | 49.949% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 119.77 Million USD | 98.59% |
| TruBridge, Inc. | 203.28 Million USD | 99.169% |
| Nutex Health, Inc. | 275.75 Million USD | 99.388% |
| Renalytix Plc | 8.53 Million USD | 80.211% |
| Sharecare, Inc. | 2.34 Million USD | 27.974% |
| Health Catalyst, Inc. | 249.06 Million USD | 99.322% |
| 10x Genomics, Inc. | 95.37 Million USD | 98.229% |
| GoodRx Holdings, Inc. | 711.07 Million USD | 99.762% |
| SCWorx Corp. | 90.35 Thousand USD | -1769.211% |
| Schrödinger, Inc. | 127.88 Million USD | 98.679% |
| HealthEquity, Inc. | 933.14 Million USD | 99.819% |
| HealthStream, Inc. | 23.22 Million USD | 92.726% |
| MSP Recovery, Inc. | 679.32 Million USD | 99.751% |
| Augmedix, Inc. | 25.84 Million USD | 93.465% |
| BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 99.954% |
| Ontrak, Inc. | 1.68 Million USD | 0.0% |
| SHL Telemedicine Ltd. | 19.85 Million USD | 91.492% |
| CareCloud, Inc. | 14.73 Million USD | 88.536% |
| Premier, Inc. | 126 Million USD | 98.66% |
| Certara, Inc. | 298.19 Million USD | 99.434% |
| GeneDx Holdings Corp. | 119.77 Million USD | 98.59% |
| OneMedNet Corporation | 5.1 Million USD | 66.891% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 99.954% |
| EUDA Health Holdings Limited | 3.37 Million USD | 49.949% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 14.73 Million USD | 88.536% |
| Mangoceuticals, Inc. | 128.67 Thousand USD | -1212.579% |
| CareMax, Inc. | 491.93 Million USD | 99.657% |
| Healthcare Triangle, Inc. | 4.31 Million USD | 60.876% |
| National Research Corporation | 38.95 Million USD | 95.664% |
| Aclarion, Inc. | 1.12 Million USD | -50.037% |
| OptimizeRx Corporation | 36.82 Million USD | 95.413% |